[PRESS RELEASE] – MIAMI, Oct. 13, 2025 – AYR Health Inc.Together with its subsidiaries and affiliates, the leading multi-state vertically integrated cannabis company in the United States announced that it had reached a new step in its debt restructuring.
This next phase will take place through a foreclosure auction, which is conducted by Odyssey Trust Co. in its capacity of collateral trustee for senior noteholders.
The trustee, at the direction of senior noteholders holding over a majority of the outstanding senior notes, has (a) delivered notifications of disposition of collateral in accordance with the Uniform Commercial Code to conduct a public sale of certain collateral assets and equity interests of certain specified AYR subsidiaries (collectively, the “debtors”) with respect to certain going‑concern operations of the company in Florida, New Jersey, Nevada, Ohio, Massachusetts, and Pennsylvania (the “assets”), as more fully outlined in the notification delivered by the trustee, and (b) published an advertisement with respect to the sale in the Wall Street Journal Distributed via Cannabis Business Times.
The auction will take place on November 10, 2025 at 10:00 a.m. Eastern Time at Paul Hastings LLP offices, located at 200 Park Ave. 26th Floor in New York City, N.Y. 10166. It can also be conducted virtually by videoconference.
Scott Davido is the interim CEO at AYR. “AYR is committed to continuing to operate and deliver high-quality products and services throughout the entire process as we transition ownership of some of the assets of the company to the winning bidder.”
David Zubricki, Ducera Partners LLC (212) 671 9717 is the best person to contact for more details regarding this sale. [email protected], and Cullen Murphy of Moelis & Co. at (212) 883-4238 or [email protected]. The sale is open to only qualified bidders who meet the requirements outlined in the bidding procedures.
AYR is committed to working with senior noteholders, as well as its other stakeholders to further the RSA.